Loading organizations...
Kaiser Permanente Ventures makes investments in promising healthcare companies targeting areas of real need. We focus on solutions that provide clear value for patients, providers, healthcare delivery systems and our larger community.
Key people at Kaiser Permanente Ventures.
Key people at Kaiser Permanente Ventures.
Kaiser Permanente Ventures (KPV) is the corporate venture capital arm of Kaiser Permanente, one of the largest integrated healthcare systems in the United States. Its mission is to advance innovation in healthcare by investing in companies that solve pressing problems for patients, providers, and health systems. KPV focuses on solutions that deliver clear, measurable value—improving outcomes, lowering costs, and enhancing access and experience across the care continuum.
The firm invests primarily in medical devices, healthcare services, and healthcare information technology, with a strong emphasis on digital health, data & analytics, and care delivery transformation. KPV typically backs growth-stage companies but also participates in earlier rounds, often alongside leading venture firms. With over 170 portfolio investments and nearly 50 exits, KPV plays a significant role in shaping the digital health ecosystem, bridging the gap between clinical insight and scalable innovation.
---
Kaiser Permanente Ventures was established to leverage the scale, clinical expertise, and operational depth of Kaiser Permanente—the integrated health system founded in 1945—to identify and support high-impact healthcare innovations. As a corporate VC, KPV was created to look beyond pure financial returns and instead focus on strategic alignment: backing companies whose solutions could improve care delivery, enhance patient engagement, or optimize health system operations.
Over time, KPV has evolved from a narrowly focused medtech investor into a broad-based healthcare VC with deep exposure to digital health, AI-driven diagnostics, virtual care, and health equity platforms. It has built a reputation for being a value-add partner, offering not just capital but also access to Kaiser Permanente’s vast clinical network, real-world data, and operational feedback. This unique positioning—backed by a major provider system yet operating with venture discipline—has allowed KPV to become a trusted co-investor alongside top-tier VCs and a launchpad for startups aiming to scale within complex health systems.
---
---
KPV sits at the intersection of healthcare delivery and technology innovation, making it a key player in the ongoing transformation of care from volume-based to value-based models. It is riding several powerful trends: the digitization of health records and workflows, the rise of AI and analytics in clinical decision-making, the expansion of virtual and home-based care, and the growing focus on mental health and chronic disease management.
Its investments reflect a bet on platforms that can scale across large, complex health systems—whether through data interoperability (e.g., Health Catalyst), remote monitoring and engagement (e.g., DexCare, Vesta Healthcare), or behavioral health integration (e.g., Headspace Health, NOCD). By backing companies that solve real operational and clinical pain points, KPV helps de-risk innovation for the broader provider community and accelerates the adoption of next-generation care models.
Moreover, KPV’s presence as a corporate VC from a major provider system influences the broader investment landscape by signaling which technologies are clinically viable and operationally sustainable. This “stamp of approval” can open doors for startups with other health systems, payers, and follow-on investors.
---
Looking ahead, Kaiser Permanente Ventures is well-positioned to continue shaping the future of care delivery through its investments. As health systems grapple with labor shortages, rising costs, and the need for more proactive, preventive, and personalized care, KPV will likely double down on AI-driven clinical tools, home-based care platforms, and solutions that improve clinician efficiency and patient engagement.
The firm may also increase its focus on health equity, social determinants of health, and interoperability infrastructure—areas where Kaiser Permanente has both strategic interest and operational leverage. As corporate venture arms gain more influence in healthcare, KPV’s ability to combine capital with real-world validation and scale will remain a powerful differentiator.
In a landscape crowded with generalist and specialized health investors, KPV stands out not just for its portfolio, but for its unique vantage point: it invests in the future of healthcare from the inside out.
Kaiser Permanente Ventures has more than 26 tracked investments across 23 companies. The latest tracked deal is $118.0M Series D in Garner Health in February 2026.
